Posted by Michael Wonder on 02 Oct 2023
Apellis announces US FDA approval of the Empaveli injector, a device to streamline self administration
2 October 2023 - Apellis Pharmaceuticals today announced that the US FDA has approved the Empaveli Injector.
The Empaveli injector is a compact, single use, on body device designed to enhance self-administration of Empaveli (pegcetacoplan), which is approved for adults with paroxysmal nocturnal haemoglobinuria.
